美股市场个股详情
VCYT Veracyte
- 20.350
- +0.160+0.79%
收盘价 05/03 16:00 (美东)
- 20.880
- +0.530+2.60%
盘后 17:30 (美东)
15.56亿总市值-19950市盈率TTM
21.240最高价20.290最低价46.38万股成交量21.000今开20.190昨收951.27万成交额0.61%换手率亏损市盈率(静)7644.76万总股本30.52052周最高1.49市净率15.49亿流通值18.61052周最低--股息TTM7611.79万流通股86.030历史最高--股息率TTM4.71%振幅4.210历史最低20.508平均价1股每手
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
Veracyte股票讨论区
专栏Today's Pre-Market Stock Movers: BMY, ADBE, MSTR, AZN and More
Select biotech/pharma names showing strength following ESMO:
$Clovis Oncology(CLVS.US)$ +11.3%, $Cardiff Oncology(CRDF.US)$ +9%, $Immatics(IMTX.US)$ +8.3%, $IDEAYA生物科学(IDYA.US)$ +8%, $Lyra Therapeutics(LYRA.US)$ +5.7%, $POINT Biopharma(PNT.US)$ +5.7%, $Edgewise Therapeutics(EWTX.US)$ +4.7%, $Concert Pharmaceuticals(CNCE.US)$ +3.6%, $Deciphera Pharmaceuticals(DCPH.US)$ +3.2%, $Veracyte(VCYT.US)$ +2.6%, $SpringWorks Therapeutics(SWTX.US)$ +2.3%,...
专栏Today's pre-market stock movers: TSLA, JPM, NVAX, CAG and more
• $Theravance Biopharma(TBPH.US)$ +15.9% (TBPH to sell all of its units in Theravance Respiratory to RPRX for over $1.5 bln)
• $Amryt Pharma(AMYT.US)$ +11.9% (FDA grants Orphan Drug Designation to Mycapssa for the treatment of Carcinoid Syndrome)
• $Green Brick Partners(GRBK.US)$ +7.3% (to join S&P SmallCap 600)
• $TransGlobe Energy(TGA.US)$ +6.9% (Transglobe Energy to be acquired by VALLCO Energy (EGY) in stock-for-stock...
专栏Today's pre-market stock movers: SE, AMD, WMT, JD and more
• $Microvast(MVST.US)$ +14.6% (In reaction to earnings)
• $Sea(SE.US)$ +11.3% (Q1 adjusted loss expands, revenue jumps)
• $京东(JD.US)$ +9.1% (beating top-line and bottom-line estimates for its latest quarter)
• $Coinbase(COIN.US)$ +6.3% (announces it is "slowing hiring so we can reprioritize our hiring needs against our highest-priority business goals")
• $Heliogen(HLGN.US)$ +5%(to restate Full Year 2021 Financials)
• $Take-Two互动软件(TTWO.US)$ +4.9% (de...
专栏Today's pre-market stock movers: TSLA, TWTR, AFRM, DWAC and more
• $Affirm Holdings(AFRM.US)$ +36.4% (also announces multi-year extension of exclusive partnership with SHOP in the US)
• $Robinhood(HOOD.US)$ +22.9% (Emergent Fidelity discloses 7.6% stake; Sam Bankman-Fried CEO of crypto exchange FTX is majority holder in fund)
• $奋进集团(EDR.US)$ +20% (in reaction to earnings)
• $Coinbase(COIN.US)$ +13% (in sympathy with HOOD news)
• $德纳维制药(DVAX.US)$ +11.5% (to join ...
ARK's buys and sells (Dec.16)
ARK's buys
$Robinhood(HOOD.US)$$Nu Holdings(NU.US)$$Veracyte(VCYT.US)$$Personalis(PSNL.US)$$PagerDuty(PD.US)$$Quantum-Si(QSI.US)$
ARK's sells
$Iovance Biotherapeutics(IOVA.US)$$LivePerson(LPSN.US)$$3D系统(DDD.US)$
Veracyte announced that it has begun rolling out its long-awaited nasal swab test for lung cancer at a limited number of clinical sites, as the company continues to accumulate data to support its future full commercial rollout.
The company also published recent findings showing that the Percepta Genomic test can more accurately group patients based on their risk of developing tumors and suspicious lung nodules.
暂无评论